Ozempic Maker Novo Nordisk Suffers Massive Fire in Denmark
- Novo says fire in Bagsvaerd was not at a production facility
- Fire follows incident at Novo site in Kalundborg on May 16
This article is for subscribers only.
Novo Nordisk A/S, the maker of Ozempic and Wegovy, lost an office building at its Danish headquarters complex due to a massive fire, in the second blaze to hit the drugmaker in less than a week.
The fire is now under control, though the building is “not able to be saved,” a Novo spokesperson said by email on Wednesday. The location isn’t used for production and the main headquarters building was not affected, Novo said.